Latest News about CRON
Recent news which mentions CRON
Cannabis Stock Gainers And Losers From March 7, 2022
March 07, 2022
From Benzinga
From Benzinga
From MarketWatch
Cronos Group Inc. (CRON) Q4 2021 Earnings Call Transcript
March 01, 2022
Tickers
CRON
From Motley Fool
Cannabis Chart Of The Week: Are You Worth More Than Your Cash? Cash-To-Market Cap Ratios Among Weed Companies
March 01, 2022
From Benzinga
Cronos Group Reports 59% YoY Revenue Increase In FY 2021, Plans To Exit Of Peace Naturals Campus In Stayner, ON
March 01, 2022
Tickers
CRON
From Benzinga
The Smartest Stocks to Buy With $700 Right Now
March 01, 2022
From Motley Fool
Earnings Scheduled For March 1, 2022
March 01, 2022
From Benzinga
From Benzinga
7 Best Stocks to Buy for a Recession
February 25, 2022
From InvestorPlace
2 Growth Stocks That Wall Street Thinks Can Double in Value
February 24, 2022
From Motley Fool
10 Biggest Price Target Changes For Tuesday
February 22, 2022
From Benzinga
Cronos Group Inc. (CRON) Q3 2021 Earnings Call Transcript
February 21, 2022
Tickers
CRON
From Motley Fool
Is This SPAC a Buy After Falling More Than 50%?
February 18, 2022
From Motley Fool
Global Cannabis Extract Market To Surpass $38B By 2030, Key Players Include Tilray, Canopy Growth, Aurora
February 17, 2022
From Benzinga
7 Tempting Sin Stocks to Profit From the Pandemic’s Most Popular Vices
February 09, 2022
From InvestorPlace
Canopy Growth and Aurora Cannabis are expected to generate less red ink when they report earnings this week
February 08, 2022
From MarketWatch
Cannabis Stock Gainers And Losers From February 1, 2022
February 01, 2022
From Benzinga
New Kids On The Block: Is A Second Wave Of Canadian Cannabis Here?
February 01, 2022
From Benzinga
Cannabis Stock Gainers And Losers From January 31, 2022
January 31, 2022
From Benzinga
2 Stocks to Avoid Like the Plague in 2022
January 29, 2022
From Motley Fool
Cannabis Stock Gainers And Losers From January 28, 2022
January 28, 2022
From Benzinga
Cannabis Stock Gainers And Losers From January 27, 2022
January 27, 2022
From Benzinga
Jefferies issues bullish note on buy-rated OrganiGram, upgrades Cronos and Hexo and cuts Tilray’s price target
January 27, 2022
From MarketWatch
Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2022
January 27, 2022
From Benzinga
Canadian Pot Stocks Had a Disappointing Year. Will 2022 Be Better?
January 25, 2022
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.